e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effect of current therapeutic modalities on epithelial barrier defects and remodelling
O. Yilmaz (Izmir, Turkey)
Source:
International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases
Session:
Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases
Session type:
Symposium
Number:
4405
Disease area:
Paediatric lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
O. Yilmaz (Izmir, Turkey). The effect of current therapeutic modalities on epithelial barrier defects and remodelling. International Congress 2014 – Epithelial barrier dysfunction: the link between paediatric and adult respiratory diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
CFTR dysfunction and its relationship to phenotype and development of new treatments restoring CFTR function
Source: Annual Congress 2013 –PG20 Cystic fibrosis: an update of the basic defects and clinical problems in CF children and adults
Year: 2013
The effect of age on lung epithelial barrier function
Source: International Congress 2018 – Intercellular communication in tissue remodelling
Year: 2018
Role of CF ion transport defect in airway inflammation and implication for antiinflammatory therapies
Source: Research Seminar 2012 - Pulmonary inflammation in paediatric respiratory disease
Year: 2012
Corticosteroids improve airway epithelial regeneration and restore oxidative stress-induced epithelial barrier dysfunction
Source: Annual Congress 2012 - New insights into airway epithelial cell physiology
Year: 2012
Beneficial effects of HDAC6 inhibition on airway epithelial barrier function
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
The roles of PCDH1 on epithelial barrier function in the airway
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012
Growth factor treatment for asthma by restoration of epithelial barrier function
Source: Annual Congress 2008 - New treatments for asthma
Year: 2008
The role of altered stem cell function in airway and alveolar repair and remodelling in COPD
Source: Eur Respir Monogr 2021; 91: 322-339
Year: 2021
Clinically validated markers of the extracellular matrix remodelling are altered by potential anti-fibrotic compounds in a human lung fibrosis ex vivo model
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis
ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017
A novel strategy to counteract airway wall remodelling in asthma: blocking the neo-vascularisation of the
lamina propria
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
Modeling the regenerative potential of airway epithelial cells
Source: Virtual Congress 2020 – (Re-)discovering the small airway epithelium in COVID-19, fibrosing lung diseases and pulmonary regeneration
Year: 2020
TGFβ1 induced loss of β-adrenergic response in human bronchial smooth muscle cells (hBSMC) is dependent on TGFβ-RI kinase activity: potential therapeutic application in treating airway diseases
Source: Annual Congress 2003 - Mechanisms of lung injury: from bench to bedside
Year: 2003
A 3D tissue-engineered airway model for the assessment of epithelial responses to novel nanotherapeutics
Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension
Year: 2021
Human rhinovirus causes increase in angiogenetic activity of lung endothelial cells – potential involvement in enhanced vasculature in asthmatics
Source: Virtual Congress 2021 – Environmental and lifestyle impacts on chronic lung disease
Year: 2021
Role of microRNAs in regulation of T17-driven airway epithelial barrier dysfunction
Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Year: 2020
ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies
Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020
Year: 2020
The
in vitro
effect of corticosteroids on components of airway remodeling
Source: Annual Congress 2010 - Lung cell biology and immunology
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept